Clinical Trial Update: Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine

View source ↗

Summary

A clinical trial update reports that Atogepant is being studied for episodic migraine and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Qulipta (atogepant)

Snippet

Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation | Conditions: Migraine Disorder, Episodic Migraine | Status: RECRUITING